Therapeutic Group: Phosphate Binders Presentation Each tablet contains Sevelamer Hydrochloride INN 400 mg. Description Sevelamer Hydrochloride is a new treatment for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. Elevated serum phosphorus levels or uncontrolled hyperphosphatemia leads to development of secondary hyperparathyroidism, renal bone disease, calcification of vascular and […]